Acquisition
Johnson & Johnson acquires Auris Health
Johnson & Johnson acquired Auris Health (~$3.4B upfront plus up to $2.35B in milestones, 2019), the Monarch endoluminal platform founded by Frederic Moll (cross-ref people-graph frederic-moll). Contingent (milestone) consideration.
full acquisition · Completed · $3.4B (contingent; CVR / earnout) · verified
Machine-readable surfaces
- Markdown mirror: /acquisitions/jnj-acquires-auris-2019.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/acquisitions/jnj-acquires-auris-2019
- Data documentation: /data
2551cc02-8442-4c32-a406-f6acd2a592e9Parties
- Acquirer
- Johnson & Johnson off-registry
- Acquired
- Auris Health off-registry
Timeline
- Closed
- 2019-04-01